全文获取类型
收费全文 | 11006篇 |
免费 | 549篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 155篇 |
妇产科学 | 215篇 |
基础医学 | 1254篇 |
口腔科学 | 264篇 |
临床医学 | 737篇 |
内科学 | 2698篇 |
皮肤病学 | 163篇 |
神经病学 | 730篇 |
特种医学 | 528篇 |
外科学 | 2039篇 |
综合类 | 66篇 |
预防医学 | 245篇 |
眼科学 | 144篇 |
药学 | 860篇 |
1篇 | |
中国医学 | 21篇 |
肿瘤学 | 1416篇 |
出版年
2023年 | 47篇 |
2022年 | 99篇 |
2021年 | 166篇 |
2020年 | 110篇 |
2019年 | 138篇 |
2018年 | 156篇 |
2017年 | 153篇 |
2016年 | 192篇 |
2015年 | 181篇 |
2014年 | 235篇 |
2013年 | 318篇 |
2012年 | 434篇 |
2011年 | 515篇 |
2010年 | 279篇 |
2009年 | 253篇 |
2008年 | 480篇 |
2007年 | 479篇 |
2006年 | 466篇 |
2005年 | 434篇 |
2004年 | 541篇 |
2003年 | 506篇 |
2002年 | 488篇 |
2001年 | 450篇 |
2000年 | 451篇 |
1999年 | 435篇 |
1998年 | 150篇 |
1997年 | 128篇 |
1996年 | 122篇 |
1995年 | 107篇 |
1994年 | 88篇 |
1993年 | 66篇 |
1992年 | 253篇 |
1991年 | 203篇 |
1990年 | 225篇 |
1989年 | 273篇 |
1988年 | 254篇 |
1987年 | 245篇 |
1986年 | 213篇 |
1985年 | 215篇 |
1984年 | 121篇 |
1983年 | 114篇 |
1982年 | 47篇 |
1979年 | 104篇 |
1978年 | 67篇 |
1977年 | 48篇 |
1974年 | 41篇 |
1972年 | 51篇 |
1971年 | 52篇 |
1970年 | 47篇 |
1969年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
141.
Pancreaticobiliary maljunction: pathophysiological and clinical aspects and the impact on biliary carcinogenesis 总被引:2,自引:0,他引:2
Yoshiro?MatsumotoEmail author Hideki?Fujii Jun?Itakura Masanori?Matsuda Yang?Yang Bunsei?Nobukawa Kohichi?Suda 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》2003,388(2):122-131
BACKGROUND: Pancreaticobiliary maljunction (PBM) is frequently associated with congenital choledochal cyst (CCBD), but differs in embryonic cause and clinical features. It is thought to develop as a misarrangement of the embryonic connections in the pancreaticobiliary ductal system, with the terminal bile duct joined to one of the ducts of the ventral pancreas. Clinical aspects are intermittent abdominal pain, relapsing acute pancreatitis, jaundice, cholangitis, and gallbladder cancer. In patients with PBM and CCBD, primary bile duct stones, acute cholangitis, and bile duct cancer are considered to result from cholestasis, regurgitation of pancreatic juice, and reciprocal reflux of bile and pancreatic juice. The mixture of bile and pancreatic juice due to recipocal reflex very likely plays an important role in biliary carcinogenesis. PATIENTS AND METHODS: We reviewed the pathophysiological and clinical aspects and biliary carcinogenesis in 250 PBM patients (169 with benign hepatobiliary and pancreatic disease, 81 with malignancy). RESULTS: PBM patients show elevated cellular proliferation activity in the gallbladder epithelia. A number of oncogenes and tumor suppressor genes have been identified and implicated in carcinogenesis, particularly the K- ras oncogene and the p53 suppressor gene. Some K- ras mutations do not appear essential for hyperplasia but may be an early event in carcinogenesis. The p53 mutations are involved in carcinogenesis in the biliary epithelium in PBM patients. 相似文献
142.
Toshimitsu Onduka Daisuke Ojima Mana Ito Katsutoshi Ito Kazuhiko Mochida Kazunori Fujii 《Archives of environmental contamination and toxicology》2013,65(4):724-732
We evaluated the acute toxicities of the main degradation products of pyridine triphenylborane (PTPB), namely, diphenylborane hydroxide (DPB), phenylborane dihydroxide (MPB), phenol, and biphenyl, to the alga Skeletonema costatum, the crustacean Tigriopus japonicus, and two teleosts, the red sea bream Pagrus major and the mummichog Fundulus heteroclitus. DPB was the most toxic of the degradation products to all four organisms. The acute toxicity values of DPB for S. costatum, T. japonicus, red sea bream, and mummichog were 55, 70, 100, and 200–310 μg/L, respectively. The degradation products were less toxic than PTPB to S. costatum and T. japonicus; however, the toxicities of DPB and PTPB to the fish species were similar. We also examined changes in the inhibition of growth rate of S. costatum as well as the percentage of immobilization of T. japonicus as end points of toxicity of PTPB after irradiation of PTPB with 432 ± 45 W/m2 of 290–700 nm wavelength light. After 7 days of irradiation with this light, the concentration of PTPB in the test solutions decreased markedly. A decrease in toxic effects closely coincided with the decrease in the concentration of PTPB caused by the irradiation. PTPB probably accounted for most of the toxicity in the irradiation test solutions. Because the concentrations of PTPB that were acutely toxic to S. costatum and T. japonicus were <10 % of the corresponding concentrations of its degradation products, PTPB probably accounted for most of the toxicity in the irradiation test solutions. 相似文献
143.
Ralph W. deVere White Alexander Tsodikov Eschelle C. Stapp Stephanie E. Soares Hajime Fujii Robert M. Hackman 《Nutrition and cancer》2013,65(8):1036-1043
The efficacy and safety of consuming high-dose isoflavone supplements for prostate cancer is not clear. A double-blind, placebo controlled, randomized trial was conducted in 53 men with prostate cancer enrolled in an active surveillance program. The treatment group consumed a supplement containing 450 mg genistein, 300 mg daidzein, and other isoflavones daily for 6 mo. Prostate-specific antigen (PSA) was measured in both groups at baseline, 3 mo, and 6 mo, and serum concentrations of genistein, daidzein, and equol were assessed at baseline and 6 mo in the treatment group. Following the completion of the 6-mo double-blind study, men were enrolled in a 6-mo open label trial with the same isoflavone-rich supplement, and PSA was measured at 3 and 6 mo. PSA concentrations did not change in either group after 6 mo or after 12 mo when the open-label study was included. The 6 mo serum concentrations of genistein and daidzein (39.85 and 45.59 μmol/l, respectively) were significantly greater than baseline values and substantially higher than levels previously reported in other studies. Equol levels did not change. Although high amounts of aglycone isoflavones may result in significantly elevated serum concentrations of genistein and daidzein, these dietary supplements alone did not lower PSA levels in men with low-volume prostate cancer. 相似文献
144.
145.
146.
147.
148.
149.
Miyatake N Takahashi K Wada J Nishikawa H Morishita A Suzuki H Kunitomi M Makino H Kira S Fujii M 《Diabetes research and clinical practice》2003,62(3):149-157
OBJECTIVE: To investigate the link between a reduction in blood pressure (BP) and daily exercise. DESIGN: Cross-sectional and longitudinal clinical intervention study with exercise education. SUBJECTS: 43 overweight Japanese men aged 32-59 years (BMI, 29.0+/-2.3 kg/m2) at baseline. Among the participants, a randomly selected 23 overweight men (BMI, 28.5+/-1.7) were further enrolled into the 10 months exercise program. MEASUREMENTS: BP was measured every week and steps per day were also recorded every day throughout the observation period. Fat distribution was evaluated by visceral fat (V) and subcutaneous fat (S) areas measured with computed tomography (CT) scanning at umbilical level, at before, 5 months and after intervention. Anthropometric parameters were also measured at same point. Aerobic exercise level, muscle strength, flexibility and calorie intake and insulin resistance (HOMA index) were investigated at before and after the study. RESULTS: In a cross sectional analysis, systolic BP (SBP) and diastolic BP (DBP) were significantly correlated with body composition. In a second longitudinal analysis, SBP was significantly reduced at 2 months and DBP was also reduced at 3 months, and almost maintained until the end of the observation period. Increasing daily walking was observed in 3 months and maintained until 10 months. Body composition, aerobic exercise level, muscle strength, flexibility and insulin resistance were significantly improved. There was positive correlation between DeltaDBP and Deltavisceral fat area (1-5, 5-10, 1-10 months). By stepwise multiple regression analysis, only Deltavisceral fat area was independently related to DeltaDBP at a significant level (1-10 months: DeltaDBP=-0.608+0.105Deltavisceral fat area, r2=0.227, P=0.0334). CONCLUSION: The present study indicated daily exercise lowers BP and visceral fat area is the critical factor for BP change. 相似文献
150.